SMAD4 and familial pancreatic carcinoma: In SMAD4-negative pancreatic cancer cells treated with the compound UA62001, the cell cycle was interrupted in synthesis (S) and Gap 2 (G2) – mitotic (M) phases [74], whereas UA62784 activated CDK1 and induced mitotic cell-cycle arrest and apoptosis [75].